Advances in the causes and management of community acquired pneumonia in adults
RG Wunderink, G Waterer - Bmj, 2017 - bmj.com
Community acquired pneumonia remains a common cause of morbidity and mortality.
Usually, the causal organism is not identified and treatment remains empiric. Recent …
Usually, the causal organism is not identified and treatment remains empiric. Recent …
Pneumonia updates on Legionella, Chlamydophila, and Mycoplasma pneumonia
SUMMARY CAP due to Legionella, Chlamydophyla, or Mycoplasma continues to be a
diagnostic challenge due to the nonspecific clinical and radiographic presentations. The …
diagnostic challenge due to the nonspecific clinical and radiographic presentations. The …
Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with …
SF van Vugt, BDL Broekhuizen, C Lammens… - Bmj, 2013 - bmj.com
Objectives To quantify the diagnostic accuracy of selected inflammatory markers in addition
to symptoms and signs for predicting pneumonia and to derive a diagnostic tool. Design …
to symptoms and signs for predicting pneumonia and to derive a diagnostic tool. Design …
Ensembles of convolutional neural network models for pediatric pneumonia diagnosis
H Liz, M Sánchez-Montañés, A Tagarro… - Future Generation …, 2021 - Elsevier
Pneumonia is a lung infection that causes 15% of childhood mortality (under 5 years old),
over 800,000 children under five every year, around 2,200 every day, all over the world. This …
over 800,000 children under five every year, around 2,200 every day, all over the world. This …
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis
MH Rozenbaum, P Pechlivanoglou… - European journal of …, 2013 - Springer
The primary objective of this meta-analysis was to estimate the prevalence of adult
community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae in Europe …
community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae in Europe …
[PDF][PDF] Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch …
WJ Wiersinga, MJ Bonten, WG Boersma, RE Jonkers… - Neth J …, 2018 - researchgate.net
Community-acquired pneumonia (CAP) is defined as an acute symptomatic infection of the
lower respiratory tract which in general develops outside of a hospital or nursing home …
lower respiratory tract which in general develops outside of a hospital or nursing home …
Pneumonia in the immunocompetent patient
JH Reynolds, G McDonald, H Alton… - The British journal of …, 2010 - academic.oup.com
Pneumonia is an acute inflammation of the lower respiratory tract. Lower respiratory tract
infection is a major cause of mortality worldwide. Pneumonia is most common at the …
infection is a major cause of mortality worldwide. Pneumonia is most common at the …
Atypical pneumonia: definition, causes, and imaging features
NP Dueck, S Epstein, T Franquet, CC Moore… - Radiographics, 2021 - pubs.rsna.org
Pneumonia is among the most common causes of death worldwide. The epidemiologic and
clinical heterogeneity of pneumonia results in challenges in diagnosis and treatment. There …
clinical heterogeneity of pneumonia results in challenges in diagnosis and treatment. There …
Guía multidisciplinar para la valoración pronóstica, diagnóstico y tratamiento de la neumonía adquirida en la comunidad
A Torres, J Barberán, M Falguera, R Menéndez… - Medicina Clínica, 2013 - Elsevier
La neumonía adquirida en la comunidad (NAC) es una enfermedad infecciosa respiratoria
aguda que tiene una incidencia que oscila entre 3 y 8 casos por 1.000 habitantes por año …
aguda que tiene una incidencia que oscila entre 3 y 8 casos por 1.000 habitantes por año …
Management of community-acquired pneumonia: a review and update
NK Brar, MS Niederman - Therapeutic advances in …, 2011 - journals.sagepub.com
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality
worldwide, affecting approximately 5.6 million patients annually in the USA, where the …
worldwide, affecting approximately 5.6 million patients annually in the USA, where the …